Erica Oberg's telehealth GLP-1 Treatments, Semaglutide or Tirzepatide medical weight loss program in Solana Beach, CA starts to make a lot of sense
[PMID: 1988059] PubMed record related to this compound for laboratory literature review
Positioning of DPP-4 Inhibitors in the Treatment Algorithm of type 2 Diabetes In 2018 the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD) published a new joint position statement for the treatment of type 2 diabetes (70, 71)
Source data Rights and permissions Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material
It's important to note that GLP-1 receptor agonists are not recommended for people with severe gastrointestinal disease, including severe gastroparesis
( PMID: 28700374 ) Kwan EA, Williams GM, Lewin-Smith MR, Lincoln MS, Lee AJ (2021) 25734 Migratory panniculitis of the pannus